НовостиBenzingaGuggenheim Initiates Coverage On LB Pharmaceuticals with Buy Rating, Announces Price Target of $80 Guggenheim Initiates Coverage On LB Pharmaceuticals with Buy Rating, Announces Price Target of $80 Benzinga 2026.10.06 12:14 (GMT+0) Открыть на Benzinga Другие новости